European Patent Office

T 0736/95 (Fresh ground of opposition/AMGEN INC.) of 09.10.2000

European Case Law Identifier
ECLI:EP:BA:2000:T073695.20001009
Date of decision
9 October 2000
Case number
T 0736/95
Petition for review of
-
Application number
83901979.1
IPC class
C07K 13/00
Language of proceedings
English
Distribution
Published in the EPO's Official Journal (A)
Other decisions for this case
-
Abstracts for this decision
-
Application title
(Met-1,des-Cys1,des-Tyr2,des-Cys3) interféron gamma humain et séquence d'ADN qui le code
Applicant name
AMGEN INC.
Opponent name
Boehringer Ingelheim GmbH
Board
3.3.04
Headnote

From the Enlarged Board of Appeal case law, decisions G 10/91 and G 1/95 in particular, and the Guidelines for the examination in the EPO follows that the aim of the patent prosecution to avoid invalid patents comes to the foreground as far as proceedings before the first instance are concerned. By adding that the Enlarged Board of Appeal did not see any reason to change the practice of the first instance, it indicated that the first instance at least needs to examine whether a fresh ground is relevant. Therefore, before declaring it inadmissible, the opposition division should have examined under Article 114(1) EPC whether the ground raised under Article 100(c) EPC could prejudice the maintenance of the patent.

Keywords
Admissibility of fresh ground of opposition - relevance
Obligation of opposition division to examine fresh ground of opposition for relevance
Remittal to first instance for further prosecution - yes
Referral to Enlarged Board of Appeal - no
Catchword
-

ORDER

For these reasons it is decided that:

1. The decision under appeal is set aside.

2. The case is remitted to the first instance for further prosecution.